Custodial was Healthequity’s largest product and service line in fiscal 2026, bringing in $636.80M of $1.31B (48%).
| Product and Service | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2021 | FY 2021 | FY 2021 | FY 2022 | FY 2022 | FY 2022 | FY 2022 | FY 2023 | FY 2023 | FY 2023 | FY 2023 | FY 2024 | FY 2025 | FY 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Service | — | — | — | — | $455.69M | $478.32M | $485.02M | ||||||||||||
| Service Revenue | $452.03M | $111.07M | $111.96M | $107.51M | — | — | — | ||||||||||||
| Custodial | — | — | — | — | $386.59M | $545.41M | $636.80M | ||||||||||||
| Custodial Revenue | $261.28M | $82.52M | $86.44M | $100.01M | — | — | — | ||||||||||||
| Interchange | — | — | — | — | $157.30M | $176.04M | $191.61M | ||||||||||||
| Interchange Revenue | $148.44M | $44.88M | $38.91M | $35.13M | — | — | — | ||||||||||||
| Total | $861.75M | $238.47M | $237.31M | $242.65M | $999.59M | $1.20B | $1.31B |
Healthequity brought in $1.31B from its three product and service lines in fiscal 2026, the year ended January 31, 2026. That was up 9.5% from $1.20B in fiscal 2025. Custodial was the largest at $636.80M (48.5%), ahead of Service at $485.02M (36.9%) and Interchange at $191.61M (14.6%).
Compared with fiscal 2025, Custodial grew fastest, up 16.8% to $636.80M. Every line above 2% of revenue grew.
Healthequity began breaking out Service in fiscal 2024, Custodial in fiscal 2024 and Interchange in fiscal 2024. Healthequity stopped reporting Service Revenue ($107.51M in fiscal 2023), Custodial Revenue ($100.01M in fiscal 2023) and Interchange Revenue ($35.13M in fiscal 2023) as separate lines.
Prior Presentation was Healthequity’s largest revenue line in fiscal 2023, bringing in $107.51M of $107.51M (100%).
| Restatement | FY 2021 | FY 2021 | FY 2021 | FY 2022 | FY 2022 | FY 2022 | FY 2023 | FY 2023 | FY 2023 |
|---|---|---|---|---|---|---|---|---|---|
| Prior Presentation | $102.53M | $298.29M | $102.73M | $104.35M | $309.18M | $108.58M | $105.11M | $349.27M | $107.51M |
| Reclassifications | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total | $102.53M | $298.29M | $102.73M | $104.35M | $309.18M | $108.58M | $105.11M | $349.27M | $107.51M |
Healthequity brought in $107.51M from its two revenue lines in fiscal 2023, the year ended October 31, 2023. That was down 69.2% from $349.27M in fiscal 2023. Prior Presentation was the largest at $107.51M (100.0%).
From fiscal 2021 to 2023, combined revenue from these revenue lines grew from $102.53M to $107.51M, a compound annual growth rate of 2.4%. Prior Presentation's share held steady at about 100.0%.
Healthequity (HQY) reports its revenue by product and service and by restatement. In fiscal 2026, Custodial was its largest product and service line, bringing in $636.80M (48.5% of the total), followed by Service at $485.02M (36.9%).
Custodial was Healthequity's largest product and service line in fiscal 2026, bringing in $636.80M, or 48.5% of the $1.31B total across its three product and service lines.
Prior Presentation was Healthequity's largest revenue line in fiscal 2023, bringing in $107.51M, or 100.0% of the $107.51M total across its two revenue lines.
Among Healthequity's product and service lines that make up at least 2% of revenue, Custodial grew fastest in fiscal 2026, up 16.8% from $545.41M to $636.80M.
Every figure comes from Healthequity's annual financial filings, as reported. Each line keeps the name Healthequity gives it, and years follow its fiscal calendar.
Healthequity's revenue by product and service goes back to fiscal 2017, with figures through fiscal 2026. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.